Determination of Apoptotic Effect of Juglone on Human Bladder Cancer TCC-SUP and RT-4 Cells: An In Vitro Study

  • J Environ Pathol Toxicol Oncol. 2018;37(2):173-181. doi: 10.1615/JEnvironPatholToxicolOncol.2018025226.
Dilek Bayram  1 ,  İlkay Armagan  1 ,  Meltem Özgöcmen  1 ,  Nurgül Senol  2 ,  Mustafa Calapoglu  3
Affiliations
  • 1. Department of Histology and Embryology, Faculty of Medicine, Süleyman Demirel University, Isparta, Turkey.
  • 2. Department of Nutrition and Dietetics, Faculty of Health Sciences, Süleyman Demirel University, Isparta, Turkey.
  • 3. Department of Chemistry, Faculty of Arts and Sciences, Süleyman Demirel University, Isparta, Turkey.
Abstract

This study aimed to investigate the effects of juglone on the human bladder carcinoma cell lines TCC-SUB and RT-4 in monolayer and spheroid cultures. Cells were treated with juglone at 24, 48, and 72 h of incubation. The activity of Caspase-3 was detected in vitro using a Caspase-3 colorimetric assay kit according to the manufacturer's instructions. The bromodeoxyuridine (BrdU) labeling index was used to determine the cells of the synthesis phase. The terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay was used to determine the death of cells in both the monolayer and spheroid cultures. The control group had a large S-phase fraction and many of the TCC-SUB and RT-4 cells nuclei were observed to be positive for BrdU. The dead cell count was higher in the TCC-SUB and RT-4 cell lines with juglone applied than in the controls. We conclude that juglone significantly inhibits the proliferation and induces the Apoptosis of TCC-SUB and RT-4 cells in vitro.